Abstract
Bronchiectasis is defined by the presence of abnormal bronchial widening and occurs as a consequence of chronic airway infection. It is an important and common cause of respiratory disease. Antibiotics are the main therapy used for the treatment of this condition. The article will review the use of antibiotics for the treatment of bronchiectasis. Antibiotics can be given as short-term therapy for exacerbations or as long-term/maintenance therapy. Antibiotics given by the inhalational route and macrolides are two relatively new classes of medication that may be useful for long-term therapy. There are significant concerns about the overuse resulting in antibiotic resistance. It should be emphasized that nearly all of the trials in the literature have only had small numbers of subjects. The data that is available describing the use of antibiotics in bronchiectasis can generally be regarded as preliminary.
Keywords: Bronchiectasis, Lung, Inhalational, Macrolide, Antibiotic Resistance, co-existent disease, cystic fibrosis, gentamicin, haemoptysis, debility
Reviews on Recent Clinical Trials
Title: Use of Antibiotics in Bronchiectasis
Volume: 7 Issue: 1
Author(s): Paul T. King and Peter W. Holmes
Affiliation:
Keywords: Bronchiectasis, Lung, Inhalational, Macrolide, Antibiotic Resistance, co-existent disease, cystic fibrosis, gentamicin, haemoptysis, debility
Abstract: Bronchiectasis is defined by the presence of abnormal bronchial widening and occurs as a consequence of chronic airway infection. It is an important and common cause of respiratory disease. Antibiotics are the main therapy used for the treatment of this condition. The article will review the use of antibiotics for the treatment of bronchiectasis. Antibiotics can be given as short-term therapy for exacerbations or as long-term/maintenance therapy. Antibiotics given by the inhalational route and macrolides are two relatively new classes of medication that may be useful for long-term therapy. There are significant concerns about the overuse resulting in antibiotic resistance. It should be emphasized that nearly all of the trials in the literature have only had small numbers of subjects. The data that is available describing the use of antibiotics in bronchiectasis can generally be regarded as preliminary.
Export Options
About this article
Cite this article as:
T. King Paul and W. Holmes Peter, Use of Antibiotics in Bronchiectasis, Reviews on Recent Clinical Trials 2012; 7 (1) . https://dx.doi.org/10.2174/157488712799363280
DOI https://dx.doi.org/10.2174/157488712799363280 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structural Insights into Chitinolytic Enzymes and Inhibition Mechanisms of Selective Inhibitors
Current Pharmaceutical Design New Highly Potent and Selective Adenosine A3 Receptor Antagonists
Current Topics in Medicinal Chemistry CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Effect of Early Treatment of Newborns by Peroral Colonization Using Non-pathogenic E. coli on the Development of Their Immuno- allergic System
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Solid-Phase and Microwave-Assisted Syntheses of 2,5-Diketopiperazines:Small Molecules with Great Potential
Combinatorial Chemistry & High Throughput Screening Clinical Values of Nitric Oxide Parameters from the Respiratory System
Current Medicinal Chemistry Cardiovascular Therapeutics Targets on the NO–sGC–cGMP Signaling Pathway: A Critical Overview
Current Drug Targets Biological Relevance of Lysophospholipids and Green Solutions for Their Synthesis
Current Organic Chemistry Anti-TNF-α Antibody Therapies in Autoimmune Diseases
Current Topics in Medicinal Chemistry Synthesis of pyridyl benzimidazoles encompassing 4-thiazolidinone derivatives as potential antimicrobial agents
Letters in Drug Design & Discovery Evaluation of HIV-1 Regulatory and Structural Proteins as Antigen Candidate in Mice and Humans
Current HIV Research Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Difficulties in Describing Allergic Disease Modulation by Pre-, Pro- and Synbiotics
Current Pharmaceutical Design Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy Adenosine Receptor Ligands-Recent Developments Part I. Agonists
Current Medicinal Chemistry Appreciating the Balance between Classical Interleukin (IL)-6 Receptor Signaling and IL-6 Trans-Signaling: Implications for Arthritis Progression
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Thiazole-based Chalcone Derivatives as Potential Anti-inflammatory Agents: Biological Evaluation and Molecular Modelling
Current Topics in Medicinal Chemistry Immunotherapeutic Targeting of Allergic Disease
Inflammation & Allergy - Drug Targets (Discontinued) Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
Current Respiratory Medicine Reviews